脑膜瘤与骨肥厚:骨刺激因子的表达及文献综述
该研究纳入149例接受手术的脑膜瘤患者,按与骨的关系分为骨肥厚型、溶骨型、浸润型及与骨无关型,用组织微阵列分析骨保护素(OPG)、胰岛素样生长因子1(IGF-1)、内皮素1(ET-1)及骨形态发生蛋白(BMP)2和4的表达。结果显示IGF-1平均表达<2%与溶骨型相关(P=0.0046),OPG平均表达<10%与溶骨型相关(P=0.048);作者认为OPG和IGF-1表达与骨肥厚发生相关,初步提示骨肥厚可能由影响成骨细胞/破骨细胞活性的成骨分子过表达所致。
要点
- 149例手术脑膜瘤中骨肥厚型11例、溶骨型11例、浸润型15例、与骨无关型108例。
- IGF-1平均表达<2%者归类为溶骨型(P=0.0046)。
- OPG平均表达<10%者归类为溶骨型(P=0.048)。
核心结论
- OPG表达和IGF-1表达与骨肥厚发生相关。
- 初步发现提示骨肥厚可由影响成骨细胞/破骨细胞活性的成骨分子过表达所致。
- 基于本研究结果,需对脑膜瘤骨肥厚骨组织进一步研究以更好理解脑膜瘤如何影响骨过度生成。
研究设计与样本
- 纳入149例接受手术的脑膜瘤患者(男39例、女110例;平均年龄62岁)。
- 按与骨的关系将脑膜瘤分为骨肥厚型、溶骨型、浸润型或与骨无关型。
- 用组织微阵列分析手术样本中OPG、IGF-1、ET-1、BMP-2和BMP-4的表达。
主要发现
- 按世界卫生组织分类,本组含Ⅰ级132例、Ⅱ级14例、Ⅲ级3例。
- 基于术前CT扫描,骨肥厚型n=11、溶骨型n=11、浸润型n=15、与骨无关型n=108;4例被排除出统计分析。
- 受试者工作特征曲线分析确定IGF-1平均值的2%截断值可区分溶骨性与成骨性病变:IGF-1平均表达<2%者归类为溶骨型(P=0.0046)。
- OPG平均表达<10%者归类为溶骨型(P=0.048)。
- 未发现其他显著关系。
关键数值与推荐
- IGF-1平均表达<2%者归类为溶骨型(P=0.0046)。
- OPG平均表达<10%者归类为溶骨型(P=0.048)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 初步发现提示骨肥厚可由影响成骨细胞/破骨细胞活性的成骨分子过表达所致,需进一步研究。
- 基于本研究结果,需对脑膜瘤骨肥厚骨组织进一步研究以更好理解脑膜瘤如何影响骨过度生成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several hypotheses have been proposed regarding the mechanisms underlying meningioma-related hyperostosis. In this study, we investigated the role of osteoprotegerin (OPG), insulin-like growth factor 1 (IGF-1), endothelin 1 (ET-1), and bone morphogenetic protein (BMP) 2 and 4. METHODS: A total of 149 patients (39 males and 110 females; mean age, 62 years) who underwent surgery were included. Depending on the relationship with the bone, meningiomas were classified as hyperostotic, osteolytic, infiltrative, or unrelated. Expression of OPG, and IGF-1, ET-1, BMP-2, and BMP-4 was evaluated by tissue microarray analysis of surgical samples. RESULTS: Our series comprised 132 cases of grade I, 14 cases of grade II, and 3 cases of grade III meningiomas, according to the World Health Organization classification. Based on preoperative computed tomography scan, the cases were classified as follows: hyperostotic, n = 11; osteolytic, n = 11; infiltrative, n = 15; unrelated to the bone, n = 108. Four cases were excluded from the statistical analysis. Using receiver operating characteristic curve analysis, we identified a 2% cutoff for the mean value of IGF-1 that discriminated between osteolytic and osteoblastic lesions; cases with a mean IGF-1 expression of <2% were classified as osteolytic (P = 0.0046), whereas those with a mean OPG expression of <10% were classified as osteolytic (P = 0.048). No other significant relationships were found. CONCLUSIONS: Expression of OPG and expression of IGF-1 were found to be associated with the development of hyperostosis. Preliminary findings suggest that hyperostosis can be caused by an overexpression of osteogenic molecules that influence osteoblast/osteoclast activity. Based on our results, further studies on hyperostotic bony tissue in meningiomas are needed to better understand how meningiomas influence bone overproduction.
引用
- Di Cristofori A, Del Bene M, Locatelli M, et al. Meningioma and Bone Hyperostosis: Expression of Bone Stimulating Factors and Review of the Literature. World Neurosurg. 2018. PMID: 29729471. doi:10.1016/j.wneu.2018.04.176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。